Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
Open Access
- 28 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 680188
- https://doi.org/10.3389/fimmu.2021.680188
Abstract
A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decreasing progression to respiratory failure and mechanical ventilation. However, some studies have highlighted its lack of efficacy in patients on high-flow oxygen and mechanical ventilation. This study uncovers some underlying immune response differences between responders and non-responders to remdesivir treatment. Immunological analyses revealed an upregulation of tissue repair factors BDNF, PDGF-BB and PIGF-1, as well as an increase in ratio of Th2-associated cytokine IL-4 to Th1-associated cytokine IFN-γ. Serological profiling of IgG subclasses corroborated this observation, with significantly higher magnitude of increase in Th2-associated IgG2 and IgG4 responses. These findings help to identify the mechanisms of immune regulation accompanying successful remdesivir treatment in severe COVID-19 patients.Funding Information
- Biomedical Research Council
- Biomedical Research Council
- Biomedical Research Council
- National Medical Research Council
- National Research Foundation Singapore
This publication has 37 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Baricitinib as potential treatment for 2019-nCoV acute respiratory diseaseThe Lancet, 2020
- Distinct profiles of Th1 and Th2 cytokines in patients with IPF, CTD-ILD, and IPAFEuropean Respiratory Journal, 2019
- Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary diseaseJournal of International Medical Research, 2018
- IgG subclass profiles in normal human sera of antibodies specific to five kinds of microbial antigensPathogens and Disease, 2013
- The effects of IL-6 on CD4 T cell responsesClinical Immunology, 2009
- The IL-21 receptor augments Th2 effector function and alternative macrophage activationJCI Insight, 2006
- Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritisAmerican Journal of Kidney Diseases, 2004
- IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patientsClinical and Experimental Immunology, 1998